While SMARCA4 mutations are rarely identified in the presence of other BAF mutations or most targetable driver oncogenes [14, 16, 19], other alterations have been reported as highly prevalent in SMARCA4‐deficient NSCLC. The gene discussed is BANF1; the disease is non-small cell lung carcinoma.